Invivyd develops advanced protection against serious viral infectious diseases, starting with SARS-CoV-2, through its unique integrated technology platform. This proprietary system focuses on assessing, monitoring, and creating leading antibodies, setting Invivyd apart in the biotechnology landscape.
